SCHEMBL17757267

SCHEMBL17757267

CON1/C(=N/Cc2cccc(Cl)c2)C2(CCNCC2)Nc2cc(Cl)c(Cl)cc21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACAT2 Q9BWD1 3/20 0.53
HTR6 P50406 7/20 0.35
HTR2A P28223 3/20 0.34
HTR2C P28335 2/20 0.34
HTR2B P41595 2/20 0.34
HTR1A P08908 2/20 0.33
HTR7 P34969 2/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
CHRM4 P08173 1/20 0.33
ADRB1 P08588 1/20 0.33
CHRM5 P08912 1/20 0.33
CHRM1 P11229 1/20 0.33
CHRM3 P20309 1/20 0.33
FPR3 P25089 1/20 0.33
HTR1D P28221 1/20 0.33
HTR1B P28222 1/20 0.33
HTR1E P28566 1/20 0.33
GPR183 P32249 1/20 0.33
HRH1 P35367 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17757951 0.87 ACAT2 (0.56) ACAT2HTR6HTR2AHTR2CHTR1A
SCHEMBL21982537 0.85 ACAT2 (0.54) ACAT2HTR6HTR2AHTR2CHTR2B
SCHEMBL17757977 0.85 ACAT2 (0.50) ACAT2HTR6HTR2AHTR2CHTR2B
SCHEMBL17757952 0.85 ACAT2 (0.56) ACAT2HTR6HTR2AHTR2CHTR2B
SCHEMBL17757279 0.81 ACAT2 (0.50) ACAT2HTR6HTR2CSIGMAR1GAA
SCHEMBL17757948 0.79 ACAT2 (0.47) ACAT2SIGMAR1TACR1MEN1KMT2A
SCHEMBL17757970 0.78 ACAT2 (0.46) ACAT2SLC6A2SLC6A4CHRM1CHRM3
SCHEMBL17757958 0.77 ACAT2 (0.42) ACAT2TACR1MEN1KMT2A
SCHEMBL17757949 0.77 ACAT2 (0.43) ACAT2HTR6SIGMAR1GAAMEN1
SCHEMBL17757953 0.76 ACAT2 (0.47) ACAT2SIGMAR1TACR1GAAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10647687-B2 Spiropyrazine derivatives as inhibitors of non-apoptotic regulated cell-death HELMHOLTZ ZENTRUM MÜNCHEN DEUTSCHES FORSCHUNGSZENTRUM FÜR GESUNDHEIT UND UMWELT (GMBH) (DE) 2020-05-12 US disclosed
WO-2016075137-A1 SPIROPYRAZINE DERIVATIVES AS INHIBITORS OF NON-APOPTOTIC REGULATED CELL-DEATH Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (DE) 2016-05-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10647687-B2 Spiropyrazine derivatives as inhibitors of non-apoptotic regulated cell-death AIFM2, BAD, AIFM1 ACAT2 1935/4885HTR6 1352/4885HTR2A 1851/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.